FR2298332B1 - - Google Patents

Info

Publication number
FR2298332B1
FR2298332B1 FR7601584A FR7601584A FR2298332B1 FR 2298332 B1 FR2298332 B1 FR 2298332B1 FR 7601584 A FR7601584 A FR 7601584A FR 7601584 A FR7601584 A FR 7601584A FR 2298332 B1 FR2298332 B1 FR 2298332B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7601584A
Other languages
French (fr)
Other versions
FR2298332A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50009469A external-priority patent/JPS5186479A/ja
Priority claimed from JP50009470A external-priority patent/JPS6024102B2/ja
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Publication of FR2298332A1 publication Critical patent/FR2298332A1/fr
Application granted granted Critical
Publication of FR2298332B1 publication Critical patent/FR2298332B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7601584A 1975-01-22 1976-01-21 Nouveaux derives de 5-fluorouraciles Granted FR2298332A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50009469A JPS5186479A (en) 1975-01-22 1975-01-22 55 furuororashirujudotainoseizohoho
JP50009470A JPS6024102B2 (ja) 1975-01-22 1975-01-22 5−フルオロウラシル誘導体の製法

Publications (2)

Publication Number Publication Date
FR2298332A1 FR2298332A1 (fr) 1976-08-20
FR2298332B1 true FR2298332B1 (en:Method) 1978-12-08

Family

ID=26344210

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7601584A Granted FR2298332A1 (fr) 1975-01-22 1976-01-21 Nouveaux derives de 5-fluorouraciles

Country Status (3)

Country Link
US (1) US4088646A (en:Method)
DE (1) DE2602175B2 (en:Method)
FR (1) FR2298332A1 (en:Method)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68935B (en:Method) * 1976-03-31 1982-03-29 Takeda Chemical Industries Ltd
JPS5446791A (en) * 1977-09-22 1979-04-12 Takeda Chem Ind Ltd Fluorouracil derivative
US4196202A (en) * 1977-12-20 1980-04-01 Taiji Okada Carcinostatic composition containing 3-N-o-toluyl-5-fluorouracil producing the same
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
US6107499A (en) * 1988-02-26 2000-08-22 Neuromedica, Inc. Dopamine analog amide
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
AU2002303164A1 (en) 2001-03-23 2002-10-08 Protarga, Inc. Fatty amine drug conjugates
EP1423107B1 (en) 2001-03-23 2012-05-09 Luitpold Pharmaceuticals, Inc. Fatty alcohol drug conjugates
JP3977162B2 (ja) * 2002-06-21 2007-09-19 株式会社バンダイナムコゲームス キャラクタ情報管理装置、プログラム及び情報記憶媒体
WO2017123823A1 (en) * 2016-01-12 2017-07-20 Bioelectron Technology Corporation Alkyl-, acyl-, urea-, and aza-uracil sulfide:quinone oxidoreductase inhibitors
RU2648998C1 (ru) * 2017-03-29 2018-03-29 Александр Александрович Озеров Способ получения монозамещенных производных урацила
RU2643520C1 (ru) * 2017-04-11 2018-02-02 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ 1,3-Бис(4-метоксибензоил)пиримидин-2,4(1Н,3Н)-дион, обладающий разрывающей поперечные сшивки гликированных белков активностью

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2949451A (en) * 1959-04-21 1960-08-16 Hoffmann La Roche Preparation of thymidine and deoxyfluorouridine, and intermediates therefor
JPS5324952B2 (en:Method) * 1973-11-28 1978-07-24

Also Published As

Publication number Publication date
DE2602175C3 (en:Method) 1979-01-11
DE2602175B2 (de) 1978-05-03
FR2298332A1 (fr) 1976-08-20
US4088646A (en) 1978-05-09
DE2602175A1 (de) 1976-07-29

Similar Documents

Publication Publication Date Title
FR2328317B1 (en:Method)
FR2298332B1 (en:Method)
FR2301570B1 (en:Method)
FR2314127B1 (en:Method)
JPS51108788A (en:Method)
JPS5439685B2 (en:Method)
JPS5518803Y2 (en:Method)
JPS5752496Y2 (en:Method)
JPS5261772U (en:Method)
JPS51117940U (en:Method)
JPS51146017U (en:Method)
CS172812B1 (en:Method)
JPS51151155U (en:Method)
JPS5237528U (en:Method)
CH594278A5 (en:Method)
BG22158A1 (en:Method)
BE826796A (en:Method)
BG22511A1 (en:Method)
AU481106A (en:Method)
CH582441A5 (en:Method)
AU479592A (en:Method)
CH376676A4 (en:Method)
CH593141A5 (en:Method)
CH590513B5 (en:Method)
CH594156A5 (en:Method)

Legal Events

Date Code Title Description
ST Notification of lapse